Scleral Lens Market Size to Surpass US$ 11.92 billion by 2031 – Growth Plus Reports


Pune, Dec. 20, 2023 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global Scleral Lens Market is expected to clock US$ 321.4 million by 2031 and to grow at a CAGR of 4.3% during the forecast period.

The global Scleral Lens Market is experiencing a robust surge, driven by advancements in eyecare technology and the growing demand for innovative solutions to address a spectrum of visual challenges. This press release delves into the key trends, developments, and the transformative impact of scleral lenses on the eyecare landscape.

Get a Sample Copy of the Research Report:


                                                   Scleral Lens Market Scope

Report Attribute Details
Market Size Value in 2022 US$ 220.0 million
Revenue Forecast in 2031 US$ 321.4 million
CAGR 4.3%
Base Year for Estimation 2022
Forecast Period 2023-2031
Historical Year 2021
Segments Covered Type, Application, End User, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Market Overview:

Scleral lenses, large-diameter contact lenses that vault over the cornea and rest on the sclera, have emerged as a transformative solution for individuals with various ocular conditions. The Scleral Lens Market is witnessing remarkable growth as these lenses offer unparalleled comfort, visual acuity, and therapeutic benefits.

Key Factors Driving Market Growth:

  1. Expanding Applications in Ocular Disorders:
    • Scleral lenses are gaining prominence in managing ocular disorders such as keratoconus, irregular astigmatism, and ocular surface diseases. Their ability to provide a smooth optical surface and a reservoir of fluid between the lens and cornea contributes to improved vision and comfort.
  2. Technological Innovations in Lens Design:
    • Ongoing advancements in lens design, including the use of advanced materials and customization options, enhance the comfort and performance of scleral lenses. These innovations cater to the unique needs of individual patients, fostering a more personalized approach to eyecare.
  3. Therapeutic Benefits for Dry Eye Syndrome:
    • Scleral lenses are proving to be a therapeutic solution for individuals suffering from severe dry eye syndrome. The lenses create a protective reservoir of fluid that lubricates the ocular surface, providing relief and improved visual comfort.
  4. Enhanced Comfort and Long-Term Wear:
    • The design and material advancements in scleral lenses contribute to extended wear times without compromising comfort. This characteristic is particularly beneficial for individuals with specific eye conditions that necessitate prolonged lens wear.

Innovations Shaping the Scleral Lens Market:

  1. Customization through Digital Imaging:
    • Digital imaging technologies enable practitioners to capture detailed maps of the ocular surface, allowing for the customization of scleral lenses based on the individual anatomy of the eye. This precise fitting enhances comfort and optical performance.
  2. Materials with Oxygen Permeability:
    • The development of materials with high oxygen permeability ensures optimal corneal health and minimizes the risk of complications associated with long-term lens wear. These breathable materials contribute to the success and acceptance of scleral lenses.
  3. Hybrid Lens Technologies:
    • Hybrid lens designs that combine the benefits of rigid and soft materials offer a unique solution for specific visual conditions. These hybrid lenses provide the comfort of soft lenses with the optical clarity of rigid lenses.
  4. Integration of Smart Technologies:
    • The integration of smart technologies, such as sensors for monitoring ocular health and the release of therapeutic agents, is an emerging trend. These innovations hold the potential to revolutionize how practitioners monitor and manage various eye conditions.

Benefits of Scleral Lenses:

  1. Improved Visual Acuity:
    • Scleral lenses provide enhanced visual acuity, especially for individuals with irregular corneal shapes or refractive errors that cannot be adequately corrected with traditional lenses. The larger lens diameter offers a stable optical surface.
  2. Comfort for Dry Eye Management:
    • The fluid reservoir created by scleral lenses provides continuous moisture to the ocular surface, making them an effective therapeutic option for managing dry eye syndrome and related discomfort.
  3. Stable Vision for Keratoconus Patients:
    • Individuals with keratoconus, a condition characterized by a thinning and bulging cornea, benefit from the stability and optical correction provided by scleral lenses. The lenses vault over the irregular corneal surface, creating a smooth refractive interface.
  4. Reduced Lens Discomfort:
    • The larger diameter of scleral lenses minimizes lens movement and reduces the likelihood of discomfort associated with lens interaction with the sensitive corneal surface.

Challenges and Opportunities:

  1. Cost and Accessibility:
    • The cost of scleral lenses and accessibility to fitting expertise remain challenges. Opportunities lie in addressing cost considerations through insurance coverage and expanding the availability of skilled practitioners.
  2. Educational Initiatives for Practitioners:
    • Training and education for eyecare practitioners on the fitting and customization of scleral lenses are essential. Opportunities exist for collaborative efforts between industry stakeholders and professional organizations to enhance practitioner proficiency.
  3. Integration with Telehealth Services:
    • The integration of scleral lens services with telehealth platforms presents an opportunity to expand access to specialized eyecare services, particularly in remote or underserved areas.

Future Outlook:

The Scleral Lens Market is poised for continued expansion as technological innovations, customization options, and a deeper understanding of ocular conditions drive advancements. Scleral lenses are becoming a cornerstone in the evolving landscape of eyecare, offering transformative solutions for individuals with diverse visual needs.

Request for Customization –

Table of Content

    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
    1. Drivers
    2. Restraints/Challenges
    3.  Opportunities
    4. Regulatory Scenario
    1. Mini-Scleral Lenses
    2. Large Scleral Lenses
    1. Ocular Surface Disease
    2. Irregular Cornea
    3. Refractive Error
    4. Others
    1. Hospitals
    2. Eye Clinics
    3. Others

Browse full TOC here


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Buy this Premium Research Report:


Scleral lenses represent a beacon of hope for individuals facing complex visual challenges, providing a comfortable and effective solution that goes beyond the capabilities of traditional contact lenses. As the market continues to evolve, scleral lenses are set to redefine standards in personalized and therapeutic eyecare.

Browse other reports:

According to the deep-dive market assessment study by Growth Plus Reports, the global immunology market was valued at US$ 92.84 billion in 2021 and is expected to register a revenue CAGR of 8.2% to reach US$ 188.70 billion by 2030.

According to the deep-dive market assessment study by Growth Plus Reports, the global bioelectronics market was valued at US$ 10.19 billion in 2021 and is expected to register a revenue CAGR of 10.62% to reach US$ 25.27 billion by 2030.

According to the deep-dive market assessment study by Growth Plus Reports, the global IV flush syringe market was valued at US$ 293.23 million in 2021 and is expected to register a revenue CAGR of 5.40% to reach US$ 472.34 million by 2030.

According to the deep-dive market assessment study by Growth Plus Reports, the global cloud-based solutions for drug discovery market was valued at US$ 2.5 billion in 2021 and is expected to register a revenue CAGR of 12.4% to reach US$ 8.04 billion by 2030.

According to the deep-dive market assessment study by Growth Plus Reports, the global colorectal cancer therapeutics market was valued at US$ 10.6 billion in 2021 and is expected to register a revenue CAGR of 9.80% to reach US$ 24.58 billion by 2030.

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] Phone no: +1 888 550 5009 Web:  Follow Us: LinkedIn | Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.